Showing results (341-350 of 391) with videos related to

Sort By:
Pageof 40
Dermatology and Therapy|September 25, 2021
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in SpainEsteban Daudén, Glauber Pacelli Gomes de Lima, Susana Armesto, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 29, 2025
Prevalence of familial dyslipidemias, degree of lipid control and relationship with atherosclerotic cardiovascular disease in the general population of Galicia. GALIPEMIAS StudyJosé Luis Díaz-Díaz, M Eugenia Ameneiros, Rosa Argüeso Armesto, et al.
Dermatologic Therapy|June 22, 2022
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice settingPablo Chicharro, Mar Llamas-Velasco, Susana Armesto, et al.
Anaesthesia, Critical Care & Pain Medicine|February 19, 2026
Videolaryngoscopy for awake tracheal intubation in patients with anticipated difficult airways: a prospective multicentre cohort studyJorge Fernández, Manuel Taboada, Ana Estany-Gestal, et al.
Actas Dermo-Sifiliograficas|April 17, 2025
Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical PracticeB Butrón-Bris, M Llamas-Velasco, S Armesto, et al.
International Journal of Dermatology|January 3, 2024
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice settingEsteban Daudén, Elena Escario, Luisa Martos-Cabrera, et al.
Actas Dermo-Sifiliograficas|June 14, 2024
Measurement Assessment of Minimal Disease Activity In Psoriasis in Spain: A National Cross-Sectional StudyG Carretero Hernández, M Ara Martín, S Armesto Alonso, et al.
Dermatologic Therapy|October 12, 2022
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patientsPablo Chicharro, Mar Llamas-Velasco, Susana Armesto, et al.
Actas Dermo-Sifiliograficas|October 10, 2024
[Translated article] Measurement Assessment of Minimal Disease Activity in Psoriasis in Spain: A National Cross-Sectional StudyG Carretero Hernández, M Ara Martín, S Armesto Alonso, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2020
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis GroupE Del Alcázar, J A Suárez-Pérez, S Armesto, et al.
Pageof 40